Robert A. Copeland
2016
In 2016, Robert A. Copeland earned a total compensation of $1.3M as President of Research and Chief Scientific Officer at Epizyme, a 17% decrease compared to previous year.
Compensation breakdown
| Bonus | $143,489 |
|---|---|
| Option Awards | $742,903 |
| Salary | $438,000 |
| Other | $8,490 |
| Total | $1,332,882 |
Copeland received $742.9K in option awards, accounting for 56% of the total pay in 2016.
Copeland also received $143.5K in bonus, $438K in salary and $8.5K in other compensation.
Rankings
In 2016, Robert A. Copeland's compensation ranked 6,829th out of 14,075 executives tracked by ExecPay. In other words, Copeland earned more than 51.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,829 out of 14,075 | 52nd |
Division Manufacturing | 2,552 out of 5,489 | 54th |
Major group Chemicals And Allied Products | 831 out of 1,895 | 56th |
Industry group Drugs | 639 out of 1,538 | 59th |
Industry Pharmaceutical Preparations | 506 out of 1,176 | 57th |
Source: SEC filing on April 28, 2017.
Copeland's colleagues
We found four more compensation records of executives who worked with Robert A. Copeland at Epizyme in 2016.